Citation Impact
Citing Papers
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
2006 StandoutScience
Astrocytes: biology and pathology
2009 Standout
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
1998 StandoutNature
Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival
2009
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
2008
Molecular dissection of reactive astrogliosis and glial scar formation
2009 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Minocycline delays disease onset and mortality in a transgenic model of ALS
2002
Trichostatin A attenuates airway inflammation in mouse asthma model
2004
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
‘A’-esterases
1989
De l’intoxication par les composés organophosphorés à l’athérosclérose : rôles de la paraoxonase 1
2003
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
1993 Standout
Nonpeptidic ligands for peptide and protein receptors
1999
Amyotrophic lateral sclerosis
2011 Standout
Chemistry, Biochemistry, and Safety of Acrylamide. A Review
2003 Standout
The Role of Phosphotriesterases in the Detoxication of Organophosphorus Compounds
1999
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
1991 Standout
Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
1996
Decoding ALS: from genes to mechanism
2016 StandoutNature
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
1999 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Cytochromes P450 and insecticide resistance
1999
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Paraoxonase protects against chlorpyrifos toxicity in mice
1995
Serum paraoxonase status: A major factor in determining resistance to organophosphates
1993
Drosophila melanogaster CYP6A8, an insect P450 that catalyzes lauric acid (ω-1)-hydroxylation
2004
A long and winding road: defining the biological role and clinical importance of paraoxonases
2006
Lack of Protection against Oxidative Modification of LDL by Avian HDL
1998
Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity
2003
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
2005 Standout
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
P450BM-3 and other Inducible Bacterial P450 Cytochromes: Biochemistry and Regulation
1991
Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats
1990
Purification of rabbit and human serum paraoxonase
1991
Age- and Gender-Related Differences in Sensitivity to Chlorpyrifos in the Rat Reflect Developmental Profiles of Esterase Activities
1998
Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis
2000 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
1998 Standout
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
2013 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
2007
Multicomponent Reactions with Isocyanides
2000 Standout
Molecular Mechanisms of Metabolic Resistance to Synthetic and Natural Xenobiotics
2006 Standout
DDT-resistance inAnopheles gambiae(Diptera: Culicidae) from Zanzibar, Tanzania, based on increased DDT-dehydrochlorinase activity of glutathione S-transferases
1995
Partial purification and properties of sheep serum ‘A’-esterases
1983
Health Effects of Chronic Pesticide Exposure: Cancer and Neurotoxicity
2004 Standout
Pesticides and oxidative stress: a review.
2004 Standout
Minocycline: far beyond an antibiotic
2013 Standout
Fenitrothion-deltamethrin cross-resistance conferred by esterases in Guatemalan Anopheles albimanus
1990
Paraoxonase and Atherosclerosis
2001 Standout
Biomarker research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations.
1996
The Yin and Yang of Oxidation in the Development of the Fatty Streak
1996 Standout
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice
2006
Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity
2007
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Excitotoxicity and Amyotrophic Lateral Sclerosis
2005
Heme-Containing Oxygenases
1996 Standout
The human serum paraoxonase/arylesterase polymorphism.
1983 Standout
New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design of Combinatorial Libraries Containing Privileged Substructures
1999
Functional Genomics of the Paraoxonase (PON1) Polymorphisms: Effects on Pesticide Sensitivity, Cardiovascular Disease, and Drug Metabolism
2003
Insecticide Resistance in Insect Vectors of Human Disease
2000 Standout
‘A’-esterase activity in the lipoprotein fraction of sheep serum
1981
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout
Glutathione S-transferase 1 and 2 in susceptible and insecticide resistant Aedes aegypti
1989
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations
2000
Works of Clive Brealey being referenced
RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis
2001
Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat
2001
Cytochrome P-450 in the housefly: Induction, substrate specificity and comparison to three rat hepatic isoenzymes
1989
Selective Endothelin A Receptor Antagonists. 3. Discovery and Structure−Activity Relationships of a Series of 4-Phenoxybutanoic Acid Derivatives
1998
RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.
2001
High-performance liquid chromatography of pirimiphos methyl and five metabolites
1979
Toxicity of pesticides to birds; the enzymic factor
1991
A‐esterase activities in relation to the differential toxicity of pirimiphos‐methyl to birds and mammals
1980
Resistance mechanisms to DDT and transpermethrin in Aedes aegypti
1984